MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Compatible

Alfacalcidol 250nanogram capsules (Phoenix Healthcare Distribution Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 250nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 250nanogram capsules (Neon Healthcare Ltd) and Alfacalcidol 250nanogram capsules (Strides Pharma UK Ltd).

Compatible

Alfacalcidol 250nanogram capsules (Sigma Pharmaceuticals Plc)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 250nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 250nanogram capsules (Neon Healthcare Ltd) and Alfacalcidol 250nanogram capsules (Strides Pharma UK Ltd).

Compatible

Alfacalcidol 250nanogram capsules (Strides Pharma UK Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 250nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 250nanogram capsules (Neon Healthcare Ltd) and Alfacalcidol 250nanogram capsules (Strides Pharma UK Ltd).

Compatible

Alfacalcidol 500nanogram capsules (A A H Pharmaceuticals Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 500nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 500nanogram capsules (Neon Healthcare Ltd).

Compatible

Alfacalcidol 500nanogram capsules (Alliance Healthcare (Distribution) Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 500nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 500nanogram capsules (Neon Healthcare Ltd).

Compatible

Alfacalcidol 500nanogram capsules (Crescent Pharma Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 500nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 500nanogram capsules (Neon Healthcare Ltd).

Compatible

Alfacalcidol 500nanogram capsules (Medihealth (Northern) Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 500nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 500nanogram capsules (Neon Healthcare Ltd).

Compatible

Alfacalcidol 500nanogram capsules (Phoenix Healthcare Distribution Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 500nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 500nanogram capsules (Neon Healthcare Ltd).

Compatible

Alfacalcidol 500nanogram capsules (Sigma Pharmaceuticals Plc)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 500nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 500nanogram capsules (Neon Healthcare Ltd).

Compatible

Alfacalcidol 500nanogram capsules (Strides Pharma UK Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 500nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 500nanogram capsules (Neon Healthcare Ltd).

Compatible

AlfaD 0.25microgram capsules (Theramex HQ UK Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 250nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 250nanogram capsules (Neon Healthcare Ltd) and Alfacalcidol 250nanogram capsules (Strides Pharma UK Ltd).

Compatible

AlfaD 0.5microgram capsules (Theramex HQ UK Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 500nanogram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 500nanogram capsules (Neon Healthcare Ltd).

Compatible

AlfaD 1microgram capsules (Theramex HQ UK Ltd)

Explore other Alfacalcidol formulations Explore other Alfacalcidol 1microgram capsules suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from One-Alpha 1microgram capsules (Neon Healthcare Ltd).

No Stability Information

Alfuzosin 2.5mg tablets (A A H Pharmaceuticals Ltd)

Explore other Alfuzosin formulations Explore other Alfuzosin 2.5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Alfuzosin 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Alfuzosin formulations Explore other Alfuzosin 2.5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.
Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.